Search for Clinical Trial Results

Sponsored By

Idiopathic Juxtafoveal Retinal Telangiectasia - 3 Studies Found

Status Study
Completed Study Name: Ranibizumab to Treat Type 2 Idiopathic Macular Telangiectasia (RAMA-Trial)
Condition: Type 2 Idiopathic Macular Telangiectasia
Date: 2007-07-18
Interventions: Drug: Intravitreal injection ranibizumab Monthly intravitreal injection of of 0.5mg ranibizumab in one e
Completed Study Name: Intravitreal Bevacizumab for Idiopathic Macular Telangiectasia
Condition:
  • Retina
  • Telangiectasis

Date: 2007-03-21
Interventions: Drug: Intravitreal Injection of Bevacizumab (1.25 mg/0.05ml)
Completed Study Name: Effect of Avastin in Juxtafoveal Telangiectasias
Condition: Telangiectasis
Date: 2006-11-30
Interventions:
  • Drug: Bevacizumab
  • Procedure: Intravitreal